Hillsborough, NJ, United States of America

Alisar S Zahr

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The Schepens Eye Research Institute, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alisar S Zahr. Retrieved from https://idiyas.com/inventor/alisar-s-zahr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alisar S Zahr: Innovator in Anti-Inflammatory Research

Introduction

Alisar S Zahr is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of medical research, particularly in the area of anti-inflammatory agents. His work is recognized for its potential impact on therapeutic applications.

Latest Patents

Alisar S Zahr holds a patent for "Endomucin as an anti-inflammatory agent." This invention provides compositions and methods for utilizing endomucin as an anti-inflammatory agent. His innovative approach aims to enhance treatment options for inflammatory conditions.

Career Highlights

Zahr is affiliated with The Schepens Eye Research Institute, Inc., where he conducts his research. His work at this esteemed institution has allowed him to explore various aspects of eye health and inflammation.

Collaborations

Alisar has collaborated with notable colleagues, including Patricia A D'Amore and Pablo Argüeso. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their field.

Conclusion

Alisar S Zahr's contributions to anti-inflammatory research exemplify the importance of innovation in medical science. His patent and ongoing work continue to pave the way for advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…